T3D Therapeutics, Inc.   Report issue

For profit Phase 2
Founded: Durham NC United States (2013)

Organization Overview

First Clinical Trial
2015
NCT02560753
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

T3D Therapeutics, Inc. | T3DTherapeutics, Inc.